These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5021396)

  • 1. [Abnormalities of lipoprotein metabolism in hepatic and biliary diseases].
    Naito C
    Saishin Igaku; 1972 Mar; 27(3):515-23. PubMed ID: 5021396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fat metabolism and the liver].
    Gros H
    Med Klin; 1973 Aug; 68(32):1021-4. PubMed ID: 4582296
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid metabolism in liver and biliary tract diseases].
    Takahashi Y; Fukazawa T
    Naika; 1968 Oct; 22(4):831-9. PubMed ID: 5707872
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoprotein metabolism in liver disease.
    Green PH
    Lab Res Methods Biol Med; 1983; 7():199-204. PubMed ID: 6353105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein metabolism in liver disease.
    Sabesin SM; Bertram PD; Freeman MR
    Adv Intern Med; 1980; 25():117-46. PubMed ID: 6987838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of disease states on the pharmacokinetics of drugs. 2. Liver and biliary diseases].
    Pfeifer S
    Pharmazie; 1991 Sep; 46(9):623-32. PubMed ID: 1798726
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of protein metabolism in patients with surgical diseases of the liver and bile ducts].
    Borovkov SA; Tsubaka NIa
    Sov Med; 1968 Mar; 31(3):87-91. PubMed ID: 5674180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of hepato-biliary diseases on drug metabolism (author's transl)].
    Pessayre D; Allemand H; Benhamou JP
    Nouv Presse Med; 1977 Oct; 6(35):3209-19. PubMed ID: 928049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter: Caffeine in biliary and liver diseases].
    Zeller W
    Med Klin; 1975 Sep; 70(36):1441-2. PubMed ID: 1177798
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of apoprotein A-I and A-II by rocket immunoelectrophoresis and its clinical application--special consideration on abnormalities in HDL metabolism in various disorders].
    Fujii S
    Fukuoka Igaku Zasshi; 1983 Jan; 74(1):1-10. PubMed ID: 6407947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of "pathologic" fraction of serum lipoproteins in patients with biliary tract, liver and non-hepatic diseases].
    Diachina EG
    Lab Delo; 1973; 8():485-6. PubMed ID: 4130981
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cholesterol metabolism disorders in digestive pathology. II].
    Rautureau J; Coste T; Rautureau M
    Arch Fr Mal App Dig; 1972 Aug; 61(8):497-506. PubMed ID: 4567365
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV; Okorokov AN
    Vrach Delo; 1982 Aug; (8):22-4. PubMed ID: 6755904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases].
    Podwysocki B; Simon K; Gładysz A
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):268-70. PubMed ID: 8234040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of carbohydrate metabolism in children with chronic hepatobiliary system diseases].
    Smiian IS; Slobodian IM; Khodorchuk NIa; Babinets' TS
    Pediatr Akus Ginekol; 1975; (4):17-9. PubMed ID: 1064835
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipoprotein lipase and glycoprotein of the blood].
    Vallino F; Pagliano F; Rugarli C
    G Gerontol; 1966 Nov; 14(11):1011-9. PubMed ID: 5998254
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver and diabetes: nutritional and metabolic relationships between metabolic hepato-cholecystopathies and the diabetic syndrome].
    Travia L; Contini S; Maggio C; Seri S
    Epatologia; 1970; 16(2):175-90. PubMed ID: 5525644
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of antioxidants in patients with chronic diseases of the hepatobiliary system (a review of the literature)].
    Epishin AV; Rudiak GI
    Vrach Delo; 1990 Apr; (4):24-7. PubMed ID: 2275156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of serum isocitrate dehydrogenase in patients with hepatobiliary diseases].
    Cremer Nicolini G
    An Fac Med Lima; 1965 Jun; 48(2):297-317. PubMed ID: 5850391
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modifications of blood magnesium in some liver and biliary tract diseases of surgical interest].
    Zarrilli L; Maffettone F; Abate S
    Rass Int Clin Ter; 1971 Apr; 51(8):451-4. PubMed ID: 5087463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.